# IBD Cancer and Serious Infection in Europe

> **NCT02377258** · — · COMPLETED · sponsor: **Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives** · enrollment: 13262 (actual)

## Conditions studied

- IBD

## Interventions

- **OTHER:** Non Interventional

## Key facts

- **NCT ID:** NCT02377258
- **Lead sponsor:** Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-04
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-16
- **Target enrollment:** 13262 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02377258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02377258, "IBD Cancer and Serious Infection in Europe". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02377258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*